Mizuho Markets Cayman LP Sells 26,818 Shares of Centene Corporation $CNC

Mizuho Markets Cayman LP lessened its holdings in Centene Corporation (NYSE:CNC) by 87.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,932 shares of the company’s stock after selling 26,818 shares during the quarter. Mizuho Markets Cayman LP’s holdings in Centene were worth $140,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in CNC. Addison Advisors LLC lifted its position in Centene by 455.6% during the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after buying an additional 606 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC bought a new position in shares of Centene in the 3rd quarter valued at about $27,000. WPG Advisers LLC increased its position in shares of Centene by 44.5% in the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after acquiring an additional 282 shares during the last quarter. Bogart Wealth LLC raised its holdings in Centene by 11,011.1% during the third quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after acquiring an additional 991 shares in the last quarter. Finally, Ameriflex Group Inc. boosted its position in Centene by 152.5% during the third quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock valued at $36,000 after purchasing an additional 610 shares during the last quarter. Institutional investors own 93.63% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. TD Cowen boosted their price target on Centene from $34.00 to $38.00 and gave the stock a “hold” rating in a research report on Wednesday, February 11th. Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a research note on Wednesday, January 21st. Mizuho set a $41.00 price target on shares of Centene and gave the company a “neutral” rating in a research note on Tuesday, March 10th. Cantor Fitzgerald restated a “neutral” rating and set a $41.00 price objective on shares of Centene in a research note on Monday, February 9th. Finally, Argus upgraded shares of Centene to a “hold” rating in a research note on Monday, February 9th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $42.06.

Centene Trading Up 0.9%

Shares of Centene stock opened at $34.77 on Tuesday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.10. The business has a fifty day simple moving average of $42.61 and a two-hundred day simple moving average of $38.51. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $66.03. The company has a market capitalization of $17.10 billion, a price-to-earnings ratio of -2.55, a P/E/G ratio of 0.76 and a beta of 0.48.

Centene (NYSE:CNC) last released its quarterly earnings data on Friday, February 6th. The company reported ($1.19) EPS for the quarter, beating the consensus estimate of ($1.22) by $0.03. The firm had revenue of $49.73 billion for the quarter, compared to the consensus estimate of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The company’s quarterly revenue was up 21.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.80 earnings per share. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Research analysts forecast that Centene Corporation will post 6.86 EPS for the current year.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.